Summary
Survival in patients with advanced cervical cancer (stage III B) treated by radical radiotherapy is low. In this study we attempted to assess the efficacy of thecis-diamminedichloroplatinum(II) (CDDP)-ifosfamide combination as neoadjuvant chemotherapy in advanced cervical cancer. The treatment schedule was: 20 mg/m2 CDDP on days 1–5; 1.5 g/m2 ifosfamide on days 1–5; and 900 mg/m2 mesna on days 1–5. Courses were given every 28 days. Radiotherapy was given 15 days after the completion of chemotherapy. A total of 26 patients were entered in this trial. Of the 24 patients evaluable for response, 15 (62.5%) achieved at least a 50% reduction in tumor volume, 6 (25%) showed stable disease, and three (12.5%) had progressive disease. At 38 months (mean follow-up) after completion of radiotherapy, 13 of the 24 (54%) evaluable patients were disease-free; 73% of the patients responding to chemotherapy vs 22% of the nonresponders remained free of disease (Fisher's exact test:P<0.02). Major hematologic depression occurred in 2 of the 26 patients evaluable for toxicity. No CNS toxicity was detected. These results are superior to those obtained by radical radiotherapy alone. Future treatment should be directed toward improving response rates as the best way of increasing both local and distant long-term disease control in these patients.
Similar content being viewed by others
References
Cueto J (1986) Resultados de la irradiacion radical en el carcinoma de cuello uterino estadios III–IV. Proceedings of the 1 st FESEO congress, Valencia, Spain, December 10–12
Goffinet DK, Bagshaw MA (1974) Clinical use of radiation sensitizing agents. Cancer Treat Rev 1:15
Goldin A (1982) Ifosfamide in experimental tumour systems. Semin Oncol 9 [Suppl 1]:14
Meanwell C, Blake A, Blackledge G, Mould JJ, Blake DR, Shaw IC, Honigsberger L, Spooner D, Williams AC, Jones JR (1985) Encephalopathy associated with ifosfamide/mesna therapy. Lancet I:406
Meanwell C, Mould J, Blackledge G (1986) Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 70:727
Meanwell CA, Blackledge G, Mould J, Labref T, Spooner D, Chebryawardana S, Stuart N, Lawton F, Kelly K, Kavanagh J (1987) Studies of chemotherapy in cervical cancer. In: Eckhardt S, Holzner JH, Nagel GA (eds) Contributions to oncology, vol 26. Karger, Basel, p 176
Perez CA (1987) Carcinoma of the cervix. In: Radiation oncology. J. B. Lippincott, Philadelphia, p 639
Thar T, Million R, Daly J (1982) Radiation treatment of carcinoma of the cervix. Semin Oncol 9:299
Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J (1981) Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 48:899
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lara, P.C., Garcia-Puche, J.L. & Pedraza, V. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother. Pharmacol. 26 (Suppl 1), S36–S38 (1990). https://doi.org/10.1007/BF00685415
Issue Date:
DOI: https://doi.org/10.1007/BF00685415